162 related articles for article (PubMed ID: 36591804)
61. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
62. LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p /LYPLA1 Axis.
Zhang Y; Zheng M; Zhang L; Yuan P; Zhou J; Wang Y; Wang H
Biochem Genet; 2022 Aug; 60(4):1298-1312. PubMed ID: 34984578
[TBL] [Abstract][Full Text] [Related]
63. LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis.
Xu J; Zhang J
J Cell Biochem; 2020 Jan; 121(1):344-352. PubMed ID: 31232491
[TBL] [Abstract][Full Text] [Related]
64. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
65. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
Zhu J; Han S
Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
[TBL] [Abstract][Full Text] [Related]
66. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract][Full Text] [Related]
67. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
68. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
Gao Y; Zou T; Liang W; Zhang Z; Qie M
Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
[TBL] [Abstract][Full Text] [Related]
69. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis.
Gao F; Feng J; Yao H; Li Y; Xi J; Yang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):776-782. PubMed ID: 30856345
[TBL] [Abstract][Full Text] [Related]
70. miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis.
Huang Z; Pang G; Huang YG; Li C
Exp Mol Pathol; 2020 Jun; 114():104384. PubMed ID: 31987844
[TBL] [Abstract][Full Text] [Related]
71. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
Takeshita N; Mori M; Kano M; Hoshino I; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Miyazawa Y; Matsubara H
Int J Oncol; 2012 Nov; 41(5):1653-61. PubMed ID: 22940702
[TBL] [Abstract][Full Text] [Related]
72. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway.
Fang J; Yang J; Chen H; Sun W; Xiang L; Feng J
Hum Cell; 2022 Sep; 35(5):1521-1534. PubMed ID: 35816228
[TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.
Wang H; Wang D; Wei Q; Li C; Li C; Yang J
Bioengineered; 2022 Apr; 13(4):9872-9884. PubMed ID: 35420507
[TBL] [Abstract][Full Text] [Related]
74.
Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
[TBL] [Abstract][Full Text] [Related]
75. Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
Yang X; Qu Y; Zhang J
Arch Med Res; 2022 Jan; 53(1):9-19. PubMed ID: 34362591
[TBL] [Abstract][Full Text] [Related]
76. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
77. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
78. LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
Lan L; Liang Z; Zhao Y; Mo Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31985002
[TBL] [Abstract][Full Text] [Related]
79. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.
Wang C; Zheng X; Shen C; Shi Y
J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668
[TBL] [Abstract][Full Text] [Related]
80. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
